A Randomized, Single-blind, Comparison Trial of Beractant (BeraksurfTM) versus Poractant Alfa (Curosurf®) in the Treatment of Respiratory Distress Syndrome in Preterm Infants

A Randomized, Single-blind, Comparison Trial of Beractant (BeraksurfTM) versus Poractant Alfa (Curosurf®) in the Treatment of Respiratory Distress Syndrome in Preterm Infants

Background: Neonatal respiratory distress syndrome (NRDS) affects approximately up to 7% of all term newborns. This study aimed to assess the efficacy and safety of investigational beractant (BeraksurfTM, Tekzima Company) in comparison with poractant alfa (Curosurf®, Chiesi Pharmaceuticals) as surfa...

Full description

Bibliographic Details
Main Authors: Manizheh Mostafa Gharehbaghi, Parvin Sarbakhsh, Hossein Mohammadbager, Safoora Gharibzadeh, Elnaz Shaseb
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2023-01-01
Series:Pharmaceutical Sciences
Subjects:
beractant
poractant alfa
respiratory distress syndrome (rds)
surfactant
surfactant replacement therapy (srt)
Online Access:https://ps.tbzmed.ac.ir/PDF/ps-29-52.pdf

Internet

https://ps.tbzmed.ac.ir/PDF/ps-29-52.pdf

Similar Items